Improve Survival News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A patient in a phase 2 trial has received the first dose of a novel combination of botensilimab and balstilimab plus agenT-979, an allogeneic cell therapy.

TME PHARMA PROVIDES POSITIVE UPDATE ON 18-MONTH SURVIVAL FOR NOX-A12 COMBINATION REGIMEN IN BRAIN CANCER AND PROVIDES STRATEGIC UPDATE INCLUDING DECISION TO ENGAGE WITH US FDA ...

Did improve survival. however, just to be clear eyed. and i use that term because representative lewis uses that term. these new kinds of chemotherapy increase survival by months, not years. they are better than what we used to have, but still it's hardly the treatment that anyone wants. doctors are really fighting to do better than this. >> elizabeth cohen, he is obviously beloved by people from both sides of the political aisle. everyone waiting anxiously as he attacks this next big fight of his life. former president jimmy carter returned to the public spotlight sunday for the first time ...

Share Preventing deaths from cancer, therapies for traumatic brain injury, new models of rehabilitation for stroke and patients on ventilation, and improving quality use of medicines in residential aged care are among projects funded by the Medical Research Future Fund (MRFF) awarded to Monash University researchers. Federal Health Minister Greg Hunt announced more than $25M in funding for Monash researchers across all areas of health and medical research, including paediatric cancer, traumatic brain injury, genomics health and stem cell therapies. Monash received funding for 13 projects, pre...